SCHEMBL3469283

SCHEMBL3469283

COc1ccc(C(=O)C=Cc2ccc(Br)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 10/20 1.00
MAOA P21397 4/20 1.00
F3 P13726 2/20 0.84
MAPT P10636 4/20 0.75
XDH P47989 2/20 0.75
MEN1 O00255 2/20 0.75
ALDH1A1 P00352 2/20 0.75
KMT2A Q03164 2/20 0.75
P4HB P07237 1/20 0.75
CALM1 P0DP23 1/20 0.75
RAB9A P51151 1/20 0.75
NPC1 O15118 1/20 0.73
LMNA P02545 1/20 0.73
CYP1B1 Q16678 3/20 0.72
HSPD1 P10809 1/20 0.72
TNFRSF1A P19438 1/20 0.72
HSPE1 P61604 1/20 0.72
BCHE P06276 1/20 0.72
CYP3A4 P08684 1/20 0.72
NFKB1 P19838 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6323431 1.00 MAOB (1.00) MAOBMAOAF3MAPTXDH
SCHEMBL5058785 1.00 MAOB (1.00) MAOBMAOAF3MAPTXDH
SCHEMBL9818339 1.00 MAOB (1.00) MAOBMAOAF3MAPTXDH
4,4'-Dimethoxychalcone SCHEMBL978242 0.92 F3 (1.00) MAOBMAOAF3MAPTXDH
4,4'-Dimethoxychalcone SCHEMBL978243 0.92 F3 (1.00) MAOBMAOAF3MAPTXDH
SCHEMBL1659833 0.87 ESR1 (0.86) MAOBMAOAF3MAPTMEN1
SCHEMBL1659832 0.87 ESR1 (0.86) MAOBMAOAF3MAPTMEN1
SCHEMBL1321123 0.86 HDAC3 (0.82) MAOBMAOAF3MAPTXDH
SCHEMBL29040010 0.86 F3 (0.82) MAOBMAOAF3MAPTXDH
SCHEMBL1321125 0.86 HDAC3 (0.82) MAOBMAOAF3MAPTXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6941051-B2 Method for producing non-linear optical organic crystal film REVEO, INC. (US) 2005-09-06 US claimed
US-20040033038-A1 Method for producing non-linear optical organic crystal film XU JIANJUN (US) 2004-02-19 US claimed
US-6577798-B2 Method for producing non-linear optical organic crystal film REVEO, INC. 2003-06-10 US claimed
US-20020041427-A1 Method for producing non-linear optical organic crystal film REVEO, INC. 2002-04-11 US claimed
WO-2002008828-A2 COMPOSITE NONLINEAR OPTICAL FILM, METHOD OF PRODUCING THE SAME AND APPLICATIONS OF THE SAME REVEO, INC. (US) 2002-01-31 WO claimed
WO-2002006890-A2 METHOD FOR PRODUCING NON-LINEAR OPTICAL ORGANIC CRYSTAL FILM REVEO, INC. (US) 2002-01-24 WO claimed
US-6303056-B1 Composite nonlinear optical film, method of producing the same and applications of the same REVEO, INC. 2001-10-16 US claimed
US-8716532-B2 One pot multicomponent synthesis of some novel hydroxy stilbene derivatives with alpha, beta-carbonyl conjugation under microwave irradiation COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-05-06 US disclosed
US-20120165567-A1 ONE POT MULTICOMPONENT SYNTHESIS OF SOME NOVEL HYDROXY STILBENE DERIVATIVES WITH ALPHA, BETA-CARBONYL CONJUGATION UNDER MICROWAVE IRRADIATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2012-06-28 US disclosed
WO-2010113005-A2 ONE POT MULTICOMPONENT SYNTHESIS OF SOME NOVEL HYDROXY STILBENE DERIVATIVES WITH ALPHA, BETA-CARBONYL CONJUGATION UNDER MICROWAVE IRRADIATION COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-10-07 WO disclosed
US-20080146574-A1 Heterocycle Substituted Carboxylic Acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2008-06-19 US disclosed
US-7329680-B2 Heterocycle substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2008-02-12 US disclosed
EP-1844043-A2 HETEROCYCLE SUBSTITUTED CARBOXYLIC ACIDS FOR THE TREATMENT OF DIABETES The Institutes for Pharmaceutical Discovery, LLC (US) 2007-10-17 EP disclosed
US-6229047-B1 NONLINEAR OPTICAL MATERIAL WHICH IS CHARACTERIZED AS HAVING A HIGH MACROSCOPIC DIPOLE MOMENT ACHIEVED THROUGH PARALLEL PACKING OF DIPOLAR MOLECULES (CRYSTALLINE AZINE BRIDGED DI-ARENE) THE CURATORS OF THE UNIVERSITY OF MISSOURI 2001-05-08 US disclosed
EP-0368169-B1 Method for producing organic crystal SUMITOMO ELECTRIC INDUSTRIES (JP) 1995-07-19 EP disclosed
US-5363797-A Method for producing organic crystal and crystal growth cell therefor SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) 1994-11-15 US disclosed
EP-0262672-B1 NON-LINEAR OPTICAL ARTICLE NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1991-11-27 EP disclosed
EP-0368169-A1 Method for producing organic crystal SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) 1990-05-16 EP disclosed
US-4892681-A BENZALACETOPHENONE DERIVATIVE, RADIATION TRANSPARENT NIPPON OIL AND FATS CO., LTD. (JP) 1990-01-09 US disclosed
EP-0262672-A1 Non-linear optical article NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1988-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165567-A1 ONE POT MULTICOMPONENT SYNTHESIS OF SOME NOVEL HYDROXY STILBENE DERIVATIVES WITH ALPHA, BETA-CARBONYL CONJUGATION UNDER MICROWAVE IRRADIATION SIK1, SIK2, HCK MAOB 1286/4885MAOA 2456/4885F3 1903/4885
US-20080146574-A1 Heterocycle Substituted Carboxylic Acids PTPRC, PTPRS, PTPRJ MAOB 378/4885MAOA 842/4885F3 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.